Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.6886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Kate Swanson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, San Fr…. Hauptthemen laut MEDLINE: Exome Sequencing, Congenital Abnormalities, Prenatal Diagnosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Fetal Health Foundation, NIH HHS.
Abstract (Originalsprache)
Objective
Analysis of exome sequencing (ES) relies on correlation with phenotypic features, but fetal phenotyping is often incomplete. The additional yield of postnatal follow‐up in cases with negative or inconclusive prenatal ES has not been demonstrated. Our objective was to assess the incremental diagnostic yield of ES reanalysis after initially negative prenatal ES for congenital anomalies incorporating features identified postnatally.
Methods
This was a secondary analysis of two prospective cohort studies of ES for fetal anomalies. We included cases in which initial ES utilizing the prenatal phenotype was not diagnostic. The primary outcome was incremental diagnostic yield of ES when incorporating postnatal findings.
Results
Eighty‐seven cases with negative or inconclusive prenatal ES and postnatal follow‐up available were included. Of those, 56 (64%) had new findings postnatally. There was an incremental yield of 2% in the entire cohort, and 7% in those with new postnatal findings. In two additional cases, postnatal evaluation suggested a specific genetic diagnosis that was not detectable with ES.
Conclusion
Among pregnancies with fetal anomalies and no clear diagnosis identified by prenatal ES, postnatal follow‐up is recommended. Reanalysis of ES results can result in a genetic diagnosis in 7% of cases with new findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, San Francisco, California, USA.
- Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, San Francisco, California, USA.
- Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, San Francisco, California, USA.
- Genomics Medicine Laboratory, University of California, San Francisco, San Francisco, California, USA.
- Institute for Human Genetics, University of California, San Francisco, San Francisco, California, USA.
- Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
ORCID-Profile: Kate Swanson, Teresa N Sparks, Anne M Slavotinek
Förderung
- NICHD NIH HHS
- Fetal Health Foundation
- NIH HHS
- Ultragenyx Pharmaceutical
- NHGRI NIH HHS
- UCSF Center for Maternal-Fetal Precision Medicine
- Brianna Marie Foundation
- National Institutes of Health
Zitieren
APA
Swanson, K., Hodoglugil, U., Sparks, T. N., Lianoglou, B. R., Slavotinek, A. M., & Norton, M. E. (2026). Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results. Prenatal Diagnosis. https://doi.org/10.1002/pd.6886
Vancouver
Swanson K, Hodoglugil U, Sparks TN, Lianoglou BR, Slavotinek AM, Norton ME. Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results. Prenatal Diagnosis. 2026. doi:10.1002/pd.6886
BibTeX
@article{Swanson2026,
author = {Swanson, Kate and Hodoglugil, Ugur and Sparks, Teresa N and Lianoglou, Billie R and Slavotinek, Anne M and Norton, Mary E},
title = {Diagnostic Yield After Postnatal Reanalysis of Prenatal Exome Sequencing Results},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.6886}
}
EUVIMED